Ausgabe 3/2021
Inhalt (8 Artikel)
Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications
Dingyu Wang, Li Sun, Guowei Zhang, Yang Liu, Zhaoguang Liang, Jing Zhao, Shuangli Yin, Mengqi Su, Song Zhang, Ying Wei, He Liu, Desen Liang, Yue Li
Cardiohemodynamic and Arrhythmogenic Effects of the Anti-Atrial Fibrillatory Compound Vanoxerine in Halothane-Anesthetized Dogs
Mihoko Hagiwara-Nagasawa, Ryuichi Kambayashi, Ai Goto, Yoshio Nunoi, Hiroko Izumi-Nakaseko, Yoshinori Takei, Akio Matsumoto, Atsushi Sugiyama
Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors
Ugur Nadir Karakulak, Elifcan Aladag, Vedat Hekimsoy, Mehmet Levent Sahiner, Ergun Baris Kaya, Necla Ozer, Salih Aksu, Haluk Demiroglu, Hakan Goker, Yahya Buyukasik, Osman Ozcebe, Nilgun Sayinalp, Ibrahim Celalettin Haznedaroglu
Nebivolol Prevents Up-Regulation of Nox2/NADPH Oxidase and Lipoperoxidation in the Early Stages of Ethanol-Induced Cardiac Toxicity
Gabriel T. do Vale, Carla B. P. da Silva, Arthur H. Sousa, Natália A. Gonzaga, Juliana M. Parente, Katiúscia M. Araújo, Michele M. Castro, Carlos R. Tirapelli
Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia
Mirjana Gotic, Miklos Egyed, Liana Gercheva, Krzysztof Warzocha, Hans Michael Kvasnicka, Heinrich Achenbach, Jingyang Wu
Divergent Electrophysiological Effects of Loperamide and Naloxone in a Sensitive Whole-Heart Model
Julian Wolfes, Christian Ellermann, Sophie Burde, Patrick Leitz, Nils Bögeholz, Kevin Willy, Michael Fehr, Florian Reinke, Lars Eckardt, Gerrit Frommeyer
Attenuation of Cardiomyocyte Hypertrophy via Depletion Myh7 using CASAAV
Peng Yue, Shutao Xia, Gang Wu, Lei Liu, Kaiyu Zhou, Hongyu Liao, Jiawen Li, Xiaolan Zheng, Yuxuan Guo, Yimin Hua, Donghui Zhang, Yifei Li